Literature DB >> 29903907

Prion gene paralogs are dispensable for early zebrafish development and have nonadditive roles in seizure susceptibility.

Patricia L A Leighton1, Richard Kanyo1, Gavin J Neil1, Niall M Pollock1, W Ted Allison2.   

Abstract

Normally folded prion protein (PrPC) and its functions in healthy brains remain underappreciated compared with the intense study of its misfolded forms ("prions," PrPSc) during the pathobiology of prion diseases. This impedes the development of therapeutic strategies in Alzheimer's and prion diseases. Disrupting the zebrafish homologs of PrPC has provided novel insights; however, mutagenesis of the zebrafish paralog prp2 did not recapitulate previous dramatic developmental phenotypes, suggesting redundancy with the prp1 paralog. Here, we generated zebrafish prp1 loss-of-function mutant alleles and dual prp1-/-;prp2-/- mutants. Zebrafish prp1-/- and dual prp1-/-;prp2-/- mutants resemble mammalian Prnp knockouts insofar as they lack overt phenotypes, which surprisingly contrasts with reports of severe developmental phenotypes when either prp1 or prp2 is knocked down acutely. Previous studies suggest that PrPC participates in neural cell development/adhesion, including in zebrafish where loss of prp2 affects adhesion and deposition patterns of lateral line neuromasts. In contrast with the expectation that prp1's functions would be redundant to prp2, they appear to have opposing functions in lateral line neurodevelopment. Similarly, loss of prp1 blunted the seizure susceptibility phenotypes observed in prp2 mutants, contrasting the expected exacerbation of phenotypes if these prion gene paralogs were serving redundant roles. In summary, prion mutant fish lack the overt phenotypes previously predicted, and instead they have subtle phenotypes similar to mammals. No evidence was found for functional redundancy in the zebrafish prion gene paralogs, and the phenotypes observed when each gene is disrupted individually are consistent with ancient functions of prion proteins in neurodevelopment and modulation of neural activity.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  PrPC; TALEN; excitotoxicity; gene editing; neural hyperactivity; neurodegeneration; neurodevelopment; prion disease; targeted mutagenesis; transcription activator-like effector nuclease; zebrafish

Mesh:

Substances:

Year:  2018        PMID: 29903907      PMCID: PMC6093244          DOI: 10.1074/jbc.RA117.001171

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

Review 1.  The lateral line microcosmos.

Authors:  Alain Ghysen; Christine Dambly-Chaudière
Journal:  Genes Dev       Date:  2007-09-01       Impact factor: 11.361

Review 2.  Epileptic activity in Alzheimer's disease: causes and clinical relevance.

Authors:  Keith A Vossel; Maria C Tartaglia; Haakon B Nygaard; Adam Z Zeman; Bruce L Miller
Journal:  Lancet Neurol       Date:  2017-04       Impact factor: 44.182

3.  Uncontrolled SFK-mediated protein trafficking in prion and Alzheimer's disease.

Authors:  Edward Málaga-Trillo; Katharina Ochs
Journal:  Prion       Date:  2016-09-02       Impact factor: 3.931

4.  Disparate evolution of prion protein domains and the distinct origin of Doppel- and prion-related loci revealed by fish-to-mammal comparisons.

Authors:  Eric Rivera-Milla; Birgit Oidtmann; Cynthia H Panagiotidis; Michael Baier; Theodoros Sklaviadis; Rudolf Hoffmann; Yi Zhou; Gonzalo P Solis; Claudia A O Stuermer; Edward Málaga-Trillo
Journal:  FASEB J       Date:  2005-12-13       Impact factor: 5.191

5.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

Review 6.  Family reunion--the ZIP/prion gene family.

Authors:  Sepehr Ehsani; Hairu Huo; Ashkan Salehzadeh; Cosmin L Pocanschi; Joel C Watts; Holger Wille; David Westaway; Ekaterina Rogaeva; Peter H St George-Hyslop; Gerold Schmitt-Ulms
Journal:  Prog Neurobiol       Date:  2010-12-14       Impact factor: 11.685

7.  Assessing proteinase K resistance of fish prion proteins in a scrapie-infected mouse neuroblastoma cell line.

Authors:  Evgenia Salta; Eirini Kanata; Christos A Ouzounis; Sabine Gilch; Hermann Schätzl; Theodoros Sklaviadis
Journal:  Viruses       Date:  2014-11-13       Impact factor: 5.048

8.  Activation of zebrafish Src family kinases by the prion protein is an amyloid-β-sensitive signal that prevents the endocytosis and degradation of E-cadherin/β-catenin complexes in vivo.

Authors:  Emily Sempou; Emiliano Biasini; Alejandro Pinzón-Olejua; David A Harris; Edward Málaga-Trillo
Journal:  Mol Neurodegener       Date:  2016-02-09       Impact factor: 14.195

9.  Guidelines for morpholino use in zebrafish.

Authors:  Didier Y R Stainier; Erez Raz; Nathan D Lawson; Stephen C Ekker; Rebecca D Burdine; Judith S Eisen; Philip W Ingham; Stefan Schulte-Merker; Deborah Yelon; Brant M Weinstein; Mary C Mullins; Stephen W Wilson; Lalita Ramakrishnan; Sharon L Amacher; Stephan C F Neuhauss; Anming Meng; Naoki Mochizuki; Pertti Panula; Cecilia B Moens
Journal:  PLoS Genet       Date:  2017-10-19       Impact factor: 5.917

10.  The ZIP-prion connection.

Authors:  Sepehr Ehsani; Mohadeseh Mehrabian; Cosmin L Pocanschi; Gerold Schmitt-Ulms
Journal:  Prion       Date:  2012-05-17       Impact factor: 3.931

View more
  9 in total

1.  Non-Synonymous variants in premelanosome protein (PMEL) cause ocular pigment dispersion and pigmentary glaucoma.

Authors:  Adrian A Lahola-Chomiak; Tim Footz; Kim Nguyen-Phuoc; Gavin J Neil; Baojian Fan; Keri F Allen; David S Greenfield; Richard K Parrish; Kevin Linkroum; Louis R Pasquale; Ralf M Leonhardt; Robert Ritch; Shari Javadiyan; Jamie E Craig; W T Allison; Ordan J Lehmann; Michael A Walter; Janey L Wiggs
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

2.  Seizures are a druggable mechanistic link between TBI and subsequent tauopathy.

Authors:  Hadeel Alyenbaawi; Richard Kanyo; Laszlo F Locskai; Razieh Kamali-Jamil; Michèle G DuVal; Qing Bai; Holger Wille; Edward A Burton; W Ted Allison
Journal:  Elife       Date:  2021-02-02       Impact factor: 8.140

3.  Sleep is bi-directionally modified by amyloid beta oligomers.

Authors:  Güliz Gürel Özcan; Sumi Lim; Patricia LA Leighton; W Ted Allison; Jason Rihel
Journal:  Elife       Date:  2020-07-14       Impact factor: 8.140

4.  In vitro generation of tau aggregates conformationally distinct from parent tau seeds of Alzheimer's brain.

Authors:  Won-Hee Nam; Young Pyo Choi
Journal:  Prion       Date:  2018-11-14       Impact factor: 3.931

5.  Interstitial 20p13 microdeletion including PRNP and adjacent genes in a fetus with congenital abnormalities-First case report.

Authors:  Pelin Onur; Mary Shaver; Mohammed Anwaruddin Iqbal
Journal:  Clin Case Rep       Date:  2021-05-04

6.  Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ9-tetrahydrocannabinol.

Authors:  Richard Kanyo; Md Ruhul Amin; Laszlo F Locskai; Danika D Bouvier; Alexandria M Olthuis; W Ted Allison; Declan W Ali
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

7.  Transcriptomic analysis of zebrafish prion protein mutants supports conserved cross-species function of the cellular prion protein.

Authors:  Niall Mungo Pollock; Patricia Leighton; Gavin Neil; W Ted Allison
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

8.  Early Exposure to THC Alters M-Cell Development in Zebrafish Embryos.

Authors:  Md Ruhul Amin; Kazi T Ahmed; Declan W Ali
Journal:  Biomedicines       Date:  2020-01-04

Review 9.  Gene-Edited Cell Models to Study Chronic Wasting Disease.

Authors:  Simrika Thapa; Cristobal Marrero Winkens; Waqas Tahir; Maria I Arifin; Sabine Gilch; Hermann M Schatzl
Journal:  Viruses       Date:  2022-03-15       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.